Vitamin C and MEK Inhibitor PD0325901 Synergistically Promote Oligodendrocytes Generation by Promoting DNA Demethylation
Molecules · 2024
DOI: 10.3390/molecules29245939 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Xinyue Ren und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Drug Research, National Center for Drug Screening, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shangha…. Hauptthemen laut MEDLINE: Ascorbic Acid, Diphenylamine, Cell Differentiation, Benzamides. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Technology of China, National Natural Science Foundation of China, Youth Innovation Promotion Association of the Chinese Academy of Sciences.
Abstract (Originalsprache)
DNA methylation and demethylation are key epigenetic events that regulate gene expression and cell fate. DNA demethylation via oxidation of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC) is typically mediated by TET (ten-eleven translocation) enzymes. The 5hmC modification is considered an intermediate state of DNA demethylation; it is particularly prevalent in the brain and is believed to play a role in the development of many cell types in the brain. Our previous studies have identified that vitamin C (Vc) and MEK inhibitor PD0325901 could significantly promote OPC (oligodendrocyte progenitor cell)-to-OL (oligodendrocyte) differentiation. Here we discovered that Vc and PD0325901 may promote OPC-to-OL differentiation by inducing DNA demethylation via hydroxymethylation. Blocking 5hmC formation almost totally blocked Vc- and PD0325901-stimulated OPC-to-OL differentiation. In addition, TET1 is not involved in Vc,- and PD0325901-promoted OL generation. We also found a synergistic effect between the two compounds in inducing OL generation, suggesting the possibility of a combination therapy for demyelination diseases in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Drug Research, National Center for Drug Screening, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
- School of Pharmacy, University of Chinese Academy of Sciences, Beijing 100049, China.
- School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China.
- Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai 264117, China.
- School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China.
ORCID-Profile: Xin Xie
Förderung
- Ministry of Science and Technology of China
- National Natural Science Foundation of China
- Youth Innovation Promotion Association of the Chinese Academy of Sciences
- Taishan Scholars Program
Zitieren
APA
Ren, X., Yang, Y., Wang, M., Yuan, Q., Suo, N., & Xie, X. (2024). Vitamin C and MEK Inhibitor PD0325901 Synergistically Promote Oligodendrocytes Generation by Promoting DNA Demethylation. Molecules. https://doi.org/10.3390/molecules29245939
Vancouver
Ren X, Yang Y, Wang M, Yuan Q, Suo N, Xie X. Vitamin C and MEK Inhibitor PD0325901 Synergistically Promote Oligodendrocytes Generation by Promoting DNA Demethylation. Molecules. 2024. doi:10.3390/molecules29245939
BibTeX
@article{Ren2024,
author = {Ren, Xinyue and Yang, Ying and Wang, Min and Yuan, Qianting and Suo, Na and Xie, Xin},
title = {Vitamin C and MEK Inhibitor PD0325901 Synergistically Promote Oligodendrocytes Generation by Promoting DNA Demethylation},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29245939}
}
EUVIMED